RESEARCH-USE BIOSIMILAR ANTIBODY
Firivumab
Monoclonal antibody · IgG1
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice.
TARGETInfluenza A HA
YMonoclonal antibody
CATALOGSC-BS-538
CATALOG NUMBERSC-BS-538
MOLECULAR WEIGHTApprox. 145.62 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice.
Firivumab is a recombinant research-use antibody directed against Influenza A HA.